Us Bancorp »

Summit Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2026-06-30 $338k 23k 14.57
2025-12-31 $5.7k 325 17.49
2025-09-30 $14k 681 20.66
2025-06-30 $7.4k 348 21.28
2025-03-31 $2.5k 128 19.29
2024-12-31 $2.9k 163 17.84
2021-09-30 $2.0k 339 5.90
2021-06-30 $8.8k 1.2k 7.16
2021-03-31 $9.5k 1.8k 5.28
2020-12-31 $999 216 4.63